Penserra Capital Management’s Global Medical REIT GMRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.15M | Buy |
165,434
+36,916
| +29% | +$256K | 0.02% | 378 |
|
2025
Q1 | $1.12M | Buy |
128,518
+22,360
| +21% | +$196K | 0.02% | 394 |
|
2024
Q4 | $819K | Sell |
106,158
-3,686
| -3% | -$28.4K | 0.02% | 465 |
|
2024
Q3 | $1.09M | Buy |
109,844
+20,460
| +23% | +$203K | 0.02% | 396 |
|
2024
Q2 | $812K | Buy |
89,384
+21,100
| +31% | +$192K | 0.01% | 481 |
|
2024
Q1 | $597K | Buy |
68,284
+8,496
| +14% | +$74.3K | 0.01% | 548 |
|
2023
Q4 | $663K | Buy |
59,788
+4,199
| +8% | +$46.6K | 0.01% | 462 |
|
2023
Q3 | $498K | Buy |
55,589
+6,996
| +14% | +$62.7K | 0.01% | 511 |
|
2023
Q2 | $443K | Buy |
48,593
+4,478
| +10% | +$40.8K | 0.01% | 568 |
|
2023
Q1 | $401K | Buy |
44,115
+8,294
| +23% | +$75.4K | 0.01% | 547 |
|
2022
Q4 | $339K | Buy |
35,821
+10,151
| +40% | +$96.1K | 0.01% | 564 |
|
2022
Q3 | $218K | Buy |
25,670
+2,500
| +11% | +$21.2K | 0.01% | 621 |
|
2022
Q2 | $260K | Buy |
23,170
+5,869
| +34% | +$65.9K | 0.01% | 626 |
|
2022
Q1 | $282K | Buy |
17,301
+3,888
| +29% | +$63.4K | 0.01% | 642 |
|
2021
Q4 | $238K | Buy |
13,413
+7,914
| +144% | +$140K | 0.01% | 636 |
|
2021
Q3 | $80K | Buy |
+5,499
| New | +$80K | ﹤0.01% | 897 |
|